CERO THERAPEUTICS HOLDINGS, INC. Operating Cash Flow
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Operating Cash Flow of -$5.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.89M.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $2.80M.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$186.61K.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$256.12K.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$16.10M.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$1.52M.
- CERO THERAPEUTICS HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$1.09M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$5.09M 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | $2.80M 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | -$16.10M 10-K · filed 2026-04-15 | ||||||
| 2025-06-30 | -$9.07M 10-Q · filed 2026-08-14 | ||||||
| 2023-12-31 | -$186.61K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | -$442.73K derived: sum of 2 quarters · filed 2024-04-02 | -$1.33M derived: sum of 3 quarters · filed 2024-04-02 | -$1.52M 10-K · filed 2024-04-02 | |||
| 2023-09-30 | -$256.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.14M derived: sum of 2 quarters · filed 2023-11-09 | -$1.34M 10-Q · filed 2023-11-09 | -$1.71M derived: sum of 4 quarters · filed 2024-04-02 | |||
| 2023-06-30 | -$883.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.08M 10-Q · filed 2023-08-14 | -$1.45M derived: sum of 3 quarters · filed 2024-04-02 | -$1.63M derived: sum of 4 quarters · filed 2024-04-02 | |||
| 2023-03-31 | -$197.78K 10-Q · filed 2023-05-12 | -$570.88K derived: sum of 2 quarters · filed 2024-04-02 | -$745.23K derived: sum of 3 quarters · filed 2024-04-02 | -$981.93K derived: sum of 4 quarters · filed 2024-04-02 | |||
| 2022-12-31 | -$373.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | -$547.45K derived: sum of 2 quarters · filed 2024-04-02 | -$784.16K derived: sum of 3 quarters · filed 2024-04-02 | -$1.09M 10-K · filed 2024-04-02 | |||
| 2022-09-30 | -$174.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$411.06K derived: sum of 2 quarters · filed 2023-11-09 | -$719.15K 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$236.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$544.80K 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | -$308.09K 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | -$697.11K 10-K · filed 2023-03-24 | ||||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |